Potential Long-Term Cost Savings In Treatment of Naïve Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabine (Single Tablet Regimen) In The Russian Federation
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1941
https://www.valueinhealthjournal.com/article/S1098-3015(15)04017-6/fulltext
Title :
Potential Long-Term Cost Savings In Treatment of Naïve Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabine (Single Tablet Regimen) In The Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04017-6&doi=10.1016/j.jval.2015.09.1941
First page :
A581
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1370